nice analysis. Though surprising to some of us, I think the 171 trial is not something that can escape the eyes of big pharma. They must know what MNKD is up to with the trial and they probably is keeping an eye on the trial results.

There is a 171 trial patient on Yahoo forum posted his dramatic lowering of his A1C level to 5.5 range. So as trial results getting more and more complete, Al can bring this to the BP for a better term of partnership deal.